Company profile
Organogenesis Holdings Inc.
NASDAQ:ORGOBiotechnology: Pharmaceutical Preparations
Clinical trials (3)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT06000410 | phase3 | completed | 2023-09-06 | 2025-08-15 | Organogenesis | A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee |
| NCT04636229 | phase3 | completed | 2020-12-14 | 2023-07-30 | Organogenesis | Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee |
| NCT01929954 | phase1_2 | terminated | 2013-07-01 | 2015-03-01 | Organogenesis | Safety Study of Gintuit™ in Subjects Requiring Socket Grafting |
FDA applications (1)
| Application | Type | Applicant | Products | |||
|---|---|---|---|---|---|---|
| BLA 125400 | BLA | Organogenesis, Inc. | ||||
Loading… | ||||||